Lonafarnib in Metastatic Breast Cancer

Clinical trial NCT00773474 · TERMINATED

Trial details

NCT number: NCT00773474
Sponsor: George Sledge
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Cancer

Start date: 2008-10-01
Primary completion: 2010-11-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.